Efficacy of Paclitaxel plus TS1 against previously treated <i>EGFR</i> mutated non-small cell lung cancer.

Efficacy of Paclitaxel plus TS1 against previously treated EGFR mutated non-small cell lung cancer.

Tseng, Yen-Han; Shih, Jen-Fu; Chao, Heng-Sheng; Chen, Yuh-Min.

Afiliação

Tseng YH; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Shih JF; Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Chao HS; Division of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
Chen YM; School of Medicine, National Yang-Ming University, Taipei, Taiwan.

PeerJ ; 7: e7767, 2019.

Article em En | MEDLINE | ID: mdl-31579626